The role of a proliferation-inducing ligand (APRIL) in the pathogenesis of rheumatoid arthritis

Scandinavian Journal of Rheumatology

Volumn 43, Issue 6, 2014, Pages 462-469

  Zhao, J ^a   Guo, J ^a   Wang, L ^a   Zhou, W ^a   Zhang, Z ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; C REACTIVE PROTEIN; TNFSF13 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; COMPARATIVE STUDY; DAS28; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GOUT; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MACROPHAGE; MALE; OSTEOARTHRITIS; PATHOGENESIS; PLASMA CELL; POSTTRAUMATIC ARTHROPATHY; RHEUMATOID ARTHRITIS; SPONDYLARTHRITIS; SYNOVIAL FLUID; SYNOVIOCYTE; SYNOVIUM; THROMBOCYTE COUNT; ARTHRITIS, RHEUMATOID; BLOOD; CHEMISTRY; CYTOLOGY; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; PLASMA CELLS; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 84914687295     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009742.2014.905630     Document Type: Article

References (26)

1. Nell VP, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M, et al. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Ann Rheum Dis 2005;64:1731-6.
2. Edelman J, Russell AS. A comparison of patients with seropositive and seronegative rheumatoid arthritis. Rheumatol Int 1983;3:47-8.
3. Im CH, Kang EH, Ryu HJ, Lee JH, Lee EY, Lee YJ, et al. Anti-cyclic citrullinated peptide antibody is associated with radiographic erosion in rheumatoid arthritis independently of shared epitope status. Rheumatol Int 2009;29:251-6.
4. Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, Robinson WH, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006;116:961-73.
5. Porter D, Madhok R, Capell H. Non-Hodgkin's lymphoma in rheumatoid arthritis. Ann Rheum Dis 1991;50:275-6.
6. Atzeni F, Doria A, Turiel M, Sarzi-Puttini P. What is the role of rituximab in the treatment of rheumatoid arthritis? Autoimmun Rev 2007;6:553-8.
7. He X, Zhong W, McCarthy TG, Weyand CM, Goronzy JJ. Increased responsiveness of rheumatoid factor-producing B cells in seronegative and seropositive rheumatoid arthritis. Arthritis Rheum 1996;39:1499-506.
8. Hahne M, Kataoka T, Schröter M, Hofmann K, IrmLer M, Bodmer JL, et al. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med 1998;6:1185-90.
9. Stein JV, Lopez-Fraga M, Elustondo FA, Carvalho-Pinto CE, Rodriguez D, Gomez-Caro R, et al. APRIL modulates B and T cell immunity. J Clin Invest 2002;109:1587-98.
10. Gabay C, Krenn V, Bosshard C, Seemayer CA, Chizzolini C, Huard B. Synovial tissues concentrate secreted APRIL. Arthritis Res Ther 2009;11:R144.
11. Xiao Y, Motomura S, Podack ER. APRIL (TNFSF13) regulates collagen-induced arthritis, IL-17 production and Th2 response. Eur J Immunol 2008;38:3450-8.
12. Nagatani K, Itoh K, Nakajima K, Kuroki H, Katsuragawa Y, Mochizuki M, et al. Rheumatoid arthritis fibroblast-like synoviocytes express BCMA and are stimulated by APRIL. Arthritis Rheum 2007;56:3554-63.
13. Miao J, Zhang K, Lv M, Li Q, Zheng Z, Han Q, et al. Circulating Th17 and Th1 cells expressing CD161 are associated with disease activity in rheumatoid arthritis. Scand J Rheumatol.Published online: 7 January 2014.doi: 10.3109/03009742.2013.846407.
14. Krenn V, Morawietz L, Häupl T, Neidel J, Petersen I, König A. Grading of chronic synovitis-a histopathological grading system for molecular and diagnostic pathology. Pathol Res Pract 2002;5:317-25.
15. Mackay F, Sierro F, Grey ST, Gordon TP. The BAFF/APRIL system: an important player in systemic rheumatic diseases. Curr Dir Autoimmun 2005;8:243-65.
16. Tan SM, Xu D, Roschke V, Perry JW, Arkfeld DG, Ehresmann GR, et al. Local production of B lymphocyte stimulator protein and APRIL in arthritic joints of patients with inflammatory arthritis. Arthritis Rheum 2003;48:982-92.
17. Schwaller J, Schneider P, Mhawech-Fauceglia P, McKee T, Myit S, Matthes T, et al. Neutrophil-derived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness. Blood 2007;109:331-8.
18. Greiner A, Plischke H, Kellner H, Gruber R. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Ann N Y Acad Sci 2005;1050:295-303.
19. Geng Y, Zhou W, Zhang ZL. A comparative study on the diversity of clinical features between the seronegative and seropositive rheumatoid arthritis patients. Rheumatol Int 2012;32:3897-901.
20. Fujinami M, Sato K, Kashiwazaki S, Aotsuka S. Comparable histological appearance of synovitis in seropositive and seronegative rheumatoid arthritis. Clin Exp Rheumatol 1997;15:11-17.
21. van Oosterhout M, Bajema I, Levarht EW, Toes RE, Huizinga TW, van Laar JM. Differences in synovial tissue infiltrates between anti-cyclic citrullinated peptide-positive rheumatoid arthritis and anti-cyclic citrullinated peptide-negative rheumatoid arthritis. Arthritis Rheum 2008;58:53-60.
22. Sun X, Zhao J, Liu R, Jia R, Sun L, Li X, et al. Elevated serum and synovial fluid TNF-like ligand 1A (TL1A) is associated with autoantibody production in patients with rheumatoid arthritis. Scand J Rheumatol 2013;42:97-101.
23. Yoshida S, Arakawa F, Higuchi F, Ishibashi Y, Goto M, Sugita Y, et al. Gene expression analysis of rheumatoid arthritis synovial lining regions by cDNA microarray combined with laser microdissection: up-regulation of inflammation-associated STAT1, IRF1, CXCL9, CXCL10, and CCL5. Scand J Rheumatol 2012;41:170-9.
24. Hatzoglou A, Roussel J, Bourgeade MF, Rogier E, Madry C, Inoue J, et al. TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-kappa B, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase. J Immunol 2000;165:1322-30.
25. Gortz B, Hayer S, Tuerck B, Zwerina J, Smolen JS, Schett G. Tumour necrosis factor activates the mitogen-activated protein kinases p38alpha and ERK in the synovial membrane in vivo. Arthritis Res Ther 2005;7:R1140-7.
26. Geng Y, Zhang ZL. Comparative study on the level of B lymphocyte stimulator (BlyS) and frequency of lymphocytes between seronegative and seropositive rheumatoid arthritis patients. Int J Rheum Dis 2012;15:478-85.